Analyst Reco. Nuvation Bio Inc.

Equities

NUVB

US67080N1019

Real-time Estimate Cboe BZX Other stock markets 11:58:59 2024-06-06 am EDT			5-day change	1st Jan Change
2.855 ^USD	+1.96%		-4.35%	+89.40%

Jun. 01	Nuvation Bio Inc. Announces Data from Pivotal Phase 2 Trust-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, Publishes in Journal of Clinical Oncology and Reports at 2024 ASCO Annual Meeting	CI
May. 14	Nuvation Bio Q1 Loss Narrows; Shares Fall After Hours	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

RBC Raises Price Target on Nuvation Bio to $5 From $4, Keeps Outperform, Speculative Risk	Apr. 17	MT
HC Wainwright Adjusts Nuvation Bio's Price Target to $8 From $5, Maintains Buy Rating	Mar. 28	MT
Jefferies Upgrades Nuvation Bio to Buy From Hold, Adjusts Price Target to $10 From $1.40	Mar. 27	MT
BTIG Upgrades Nuvation Bio to Buy From Neutral, Price Target is $5	Mar. 26	MT
H.C. Wainwright Raises Price Target on Nuvation Bio to $5 From $4.50, Maintains Buy Rating	Mar. 07	MT
RBC Cuts Price Target on Nuvation Bio to $4 From $5, Keeps Outperform, Speculative Risk	Nov. 06	MT
RBC Cuts Price Target on Nuvation Bio to $5 From $6, Keeps Outperform, Speculative Risk	23-05-05	MT
Jefferies Downgrades Nuvation Bio to Hold From Buy, Adjusts Price Target to $2 From $5	23-01-06	MT
HC Wainwright Adjusts Price Target on Nuvation Bio to $4.50 From $14, Reiterates Buy Rating	22-08-22	MT
BTIG Downgrades Nuvation Bio to Neutral From Buy	22-08-02	MT
BMO Capital Lowers Nuvation Bio to Market Perform From Outperform, Price Target to $2.50 From $8	22-08-02	MT
Wedbush Adjusts Price Target for Nuvation Bio to $5 From $17 on Discontinuation of NUV-422, Maintains Outperform Rating	22-08-01	MT
RBC Cuts Price Target on Nuvation Bio to $14 From $15, Maintains Outperform Rating, Speculative Risk Qualifier	22-05-11	MT
Wedbush Adjusts Nuvation Bio Price Target to $17 From $23, Maintains Outperform Rating	22-05-10	MT
HC Wainwright Starts Nuvation Bio at Buy With $14 Price Target	22-05-04	MT
BMO Capital Adjusts Nuvation Bio's Price Target to $12 From $17, Keeps Outperform Rating	22-03-22	MT
NUVATION BIO : Wedbush Adjusts Nuvation Bio's Price Target to $23 From $21, Keeps Outperform Rating	21-08-13	MT
NUVATION BIO : Wedbush Adjusts Nuvation Bio's Price Target to $21 From $20, Keeps Outperform Rating	21-05-18	MT
NUVATION BIO : RBC Capital Starts Nuvation Bio at Outperform with $15 Price Target	21-04-06	MT
NUVATION BIO : Jefferies Starts Nuvation Bio at Buy With $20 Price Target	21-03-08	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Nuvation Bio Inc.

Equities

NUVB

US67080N1019

Analyst Reco.

Filters